300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Gaming
Health Care
Agriculture (AgTech)
Facebook
Blockchain
Social Network
B2B
Video Games
Medical Device
Big Data
Wellness
Mobile
Education
Automotive
Hospitality
Sports
Legal
Biotechnology
eSports
Consumer
Construction
Software
Renewable Energy
Crowdfunding
Venture Capital
Theatre
Fashion
Medical
Social
Recruiting
Beauty
Web3
Cannabis
Infrastructure
LGBT
Mobile Apps
Celebrity
Life Science
Climate
Music
Wine and Spirits
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Food and Beverage
Finance
Financial Services
Social Media
Publishing
Franchise
Mobile Advertising
Android
Non Profit
Internet
Sustainability
Enterprise
Community
Media (Entertainment)
Hardware
Biotech
Impact
Proptech
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Japan
Ireland
South Africa
Canada
United Kingdom
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Spain
Albania
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Angola
Europe
Peru
Cyprus
Slovenia
San Marino
Ukraine
Qatar
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 15 Biotech Angel Investors in Mexico (August 2026)

The most active angel investors investing in Mexico Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Mexico Biotech startup companies. Find investors to raise a Seed, Series A or Angel round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Matt Cutts
Angel
1 United States, Canada, Mexico Seed, Angel, Series A SaaS, Health Care, Medical $493k–$2.8M
Paul Buchheit
Angel
1 United States, Canada, India Seed, Series A, Angel Software, Artificial Intelligence, E-Commerce $100k–$14M
Thomas James
Angel
1 Mexico Seed Health Care, Biotechnology, Health Diagnostics $52k–$1.9M
Mark Gormley
Angel
1 United States, Canada Private Equity, Series A, Secondary Market Insurance, Risk Management, Service Industry
Sohail Prasad
Angel
1 United States, France, Mexico Seed, Series A Software, Human Resources, Financial Services $1.1M–$25M
Robert Stavis
Angel
1 United States, Canada, United Kingdom Series C, Series B, Series A Financial Services, FinTech, Finance $3.9M–$126M
Geoffrey KALISH
Angel
1 Mexico Series A AgTech, Seafood, Biotechnology
Jason Burke
Angel
1 United States, Mexico Seed, Pre-Seed, Angel Health Care, Information Technology, Internet
Jessica Livingston
Angel
1 United States, Mexico Seed, Angel Medical Device, Education, Health Care
Bob Goodman
Angel
1 United States, Mexico, Germany Series B, Series C, Series A Software, SaaS, Information Technology
Ashton Kutcher
Angel
1 United States, Germany, Canada Seed, Series A, Series B Software, E-Commerce, Apps
Eric Urhane
Angel
1 United States, Mexico, Singapore Seed, Angel Software, Health Care, Biotechnology $1.1M–$1.9M
Elizabeth Iorns
Angel
1 United States, Canada, Mexico Seed, Pre-Seed Software, SaaS, Health Care $1.9M–$3M
Dan Knox
Angel
1 Mexico, United States Seed Finance, Health Care, Crowdfunding
Jeff Horing
Angel
1 United States, Israel, Canada Series B, Series A, Series C Software, Artificial Intelligence, Information Technology $8.7M–$210M
Access all 15 angel investors in Mexico Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Matt Cutts
Angel · San Francisco, California, United States · 1 investments in Mexico Biotech startups

Matt Cutts joined Google as a Software Engineer in January 2000. Before Google, he was working on his Ph.D. in computer graphics at the University of North Carolina at Chapel Hill. He has an M.S. from UNC-Chapel Hill, and B.S. degrees in both mathematics and computer science from the University of Kentucky.Matt wrote SafeSearch, which isGoogle's family filter. In addition to his experience at Google, Matt held a top-secret clearance while working for the Department of Defense, and he's also worked at a game engine company. He claims that Google is the most fun by far.Matt talks about webmaster-related issues on his

Show more...

Investment focus

  • Industry: SaaS, Health Care, Medical
  • Stage:Seed, Angel, Series A
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 11
  • Round size: Seed $493k–$2.8M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • X-ZELL — Early, pain-free cancer cell detection
  • Meter Feeder — Easily pay for parking through MeterFeeder
Show all investments...

Paul Buchheit
Angel · Mountain View, California, United States · 1 investments in Mexico Biotech startups

Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, E-Commerce
  • Stage:Seed, Series A, Angel
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 153
  • Round size: Seed $1.1M–$5M; Angel $100k–$1.6M; Series A $2.5M–$14M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
  • BuildForever — BuildForever build products that feel personal, magical and deeply human.
  • Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Show all investments...

Thomas James
Angel · 1 investments in Mexico Biotech startups

Thomas James

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: Mexico

Investor stats

  • Total investments: 2
  • Round size: Seed $52k–$1.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • Miproto — Miproto is changing manufacturing for both businesses and individuals. The website allows anybody to upload their product idea, and have it developed by the same engineers working on the worlds most advanced technologies, into 3D CAD files, 3D printed models, prototypes and even mass manufactured items.The company brings together the disjointedprocess into one slick system – reducing times from months to days and weeks. Whilst reducing costs by cutting admin roles and multiple projects managers across facilities.Miproto provides a platform for product design that connects in house engineers with a global army of 24/7 freelancers, client projects, CAD files, 3D printing machines, CNC factories, mass manufacturing facilities, and even a 2D printer for invoicing!Whilst Student, Joey McConnel, was able to develop his university project component into a manufactured piece, the Design Council used Miproto to design and 3D print 200 awards for the designers involved in the London 2012 Olympics. At the same time, top secret medical devices where being prototyped in the London 3D printers. These were being designed over night by a selection of client chosen freelance engineers, based in America and Asia.
Show all investments...

Mark Gormley
Angel · New York, New York, United States · 1 investments in Mexico Biotech startups

Mark K. Gormley is a Partner at Lee Equity Partners. Prior to joining Lee Equity in 2006, Mr. Gormley was a Partner at Capital Z Financial Services Partners (“CZFS”), a leading financial services private equity firm, where he played a leading role in the operations and investment activities of the $1.85 billion fund. Mr. Gormley co-founded CZFS in1998 and shared responsibility for the oversight of all of the firm's investment and monitoring activities. Prior to founding CZFS, Mr. Gormley served as a Managing Director at Donaldson, Lufkin & Jenrette (“DLJ”), specializing in the insurance and asset management industries. While at DLJ, Mr. Gormley worked on corporate finance and merger and acquisition assignments, as well as on principal related activities on behalf of DLJ Merchant Banking. Prior to joining DLJ in 1989, he was a founding member of the Insurance Group at Merrill Lynch in 1985. Mr. Gormley serves or has served as a director of numerous public and private companies, including The Edelman Financial Group, Skopos Financial Group, Captive Resources, Carlile Bancshares, PDR Network, MidCap Financial, Universal American, Permanent General, NewStar Financial, British Marine Holdings, Catlin Group, Bank Handlowy, Ceska Sporitelna, NACOLAH among others. Mr. Gormley received a B.S.B.A. cum laude in Finance and Economics from the University of Denver and an M.B.A. from New York University.

Show more...

Investment focus

  • Industry: Insurance, Risk Management, Service Industry
  • Stage:Private Equity, Series A, Secondary Market
  • Geography: United States, Canada

Investor stats

  • Total investments: 5
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
  • Axis Insurance — Axis Insurance stands at the forefront of the insurance industry, drawing on decades of expertise and a forward-thinking approach.
  • Pure Financial Advisors — Pure Financial Advisors provides financial advice for pre-retirees and retirees. Michael Fenison and Paul M. Miller founded it in 2007, with its headquarters in San Diego in California.
Show all investments...

Sohail Prasad
Angel · San Francisco, California, United States · 1 investments in Mexico Biotech startups

Sohail is the Founder & CEO of Destiny (D/XYZ).Sohail is also Founder & former Co-CEO of Forge, the stock market for private companies. He has an extensive background in product management, engineering, and business. As an eighteen-year-old, he was among the youngest founders to go through Y Combinator. Over the years, Sohail hasadvised and invested in over 100 startups, including notable startups such as Zenefits and Rappi. He continues to invest actively through S2 Capital, and serves as its Founding Partner. Prior to founding Equidate, Sohail managed mobile product at Zynga. He previously joined mobile advertising firm Chartboost as its second engineering hire, and has held roles at Google and the MIT Media Lab. Sohail was awarded TCU's Texas Youth Entrepreneur of the Year award in 2010, and was later named a Thiel Fellow by the Thiel Foundation. He previously attended Carnegie Mellon University where he studied Electrical & Computer Engineering.

Show more...

Investment focus

  • Industry: Software, Human Resources, Financial Services
  • Stage:Seed, Series A
  • Geography: United States, France, Mexico

Investor stats

  • Total investments: 12
  • Round size: Seed $1.1M–$7M; Series A $11M–$25M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • Wethenew — Acquistate le vostre autentiche sneakers prodotti streetwear in edizione limitata in modo sicuro e protetto su wethenew.com!
  • Series — Series provides full-stack enterprise financial services designed for institutions & enterprises.
Show all investments...

Robert Stavis
Angel · New York, New York, United States · 1 investments in Mexico Biotech startups

Robert Michael Stavis is based out of Larchmont, New York and is the Partner of Bessemer Venture Partners. Robert previously worked at NewSchools Venture Fund as a Director. Robert Stavis attended the University of Pennsylvania.

Show more...

Investment focus

  • Industry: Financial Services, FinTech, Finance
  • Stage:Series C, Series B, Series A
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 35
  • Round size: Series A $3.9M–$38M; Series B $9.3M–$126M; Series C $10M–$32M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • LNTS — LNTS has recognized the deficiencies in healthcare and through our proprietary technology and solution, we are making rehabilitation and performance far more efficient for patients, clinicians and providers. LNTSConnect.com
  • Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
  • Flower Company — We sell weed on the internet. Thousands of products delivered overnight throughout California from Humboldt to San Diego
Show all investments...

Geoffrey KALISH
Angel · 1 investments in Mexico Biotech startups

Mr. Kalish is a Partner at Aquiline Capital Partners. Previously, Mr. Kalish was also the Founder and Managing Director at Venturion Capital. He has served on the boards of numerous financial services companies in Europe and the US. He holds a history degree from Columbia and a masters degree in public policy from Harvard.

Show more...

Investment focus

  • Industry: AgTech, Seafood, Biotechnology
  • Stage:Series A
  • Geography: Mexico

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
Show all investments...

Jason Burke
Angel · Boston, Massachusetts, United States · 1 investments in Mexico Biotech startups

Jason Burke is the Co-founder, Managing Director, and Investor of TBD Angels and the VP of Strategy and Business Development of Xandr. Prior to that, he was the Chief Strategy Officer for clypd, a Boston-based startup building an advertising technology platform exclusively for the TV industry and designed to empower media companies with actionablesales tools. In his role, Burke focuses on a forward-looking platform and business strategy, corporate development, partnerships, and management of clypd's strategic commercial deals.As one of the first employees at clypd, Burke spent over 3 years as VP, Product leading the product & operations teams in bringing innovative products to the $180B television advertising market. Prior to clypd, Burke spent six years building ad technology products for online video at ScanScout and Tremor Video where he had responsibility for product management, technical strategy and operations efforts.Jason is a leader with the unique experience of working with executive customer teams and internal product development/engineering groups to drive business while also solving software and implementation challenges with internal and external technical teams. He is also a frequent contributor to industry publications and participant on advertising technology and media conference presentations and panels. Jason holds several software patents focused on inventions in advertising technology and media.Jason is also an investor in early-stage companies across several verticals. He feels privileged to invest in and collaborate with talented founding teams seeking to change the world with innovative products & businesses.Jason is based in Boston and has degrees in Computer Science and Engineering Psychology from Tufts University.

Show more...

Investment focus

  • Industry: Health Care, Information Technology, Internet
  • Stage:Seed, Pre-Seed, Angel
  • Geography: United States, Mexico

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • Eva — Eva develops an accessible and non-invasive wearable device designed to detect breast cancer risks. The company's wearable device is equipped with tactile sensors which are designed to map the surface of the breast and surrounding areas, allowing women to keep a track on the changes in breast temperature, size, and weight, with the help ofbiosensors inside the cup which constantly monitors information.
  • Wrangle — Wrangle organizes requests in your Slack team channel. Automatically assign approvals and tasks for your team to follow up and track their status.
  • WorkAround — WorkAround is the accurate, scalable solution for adding human input to your data using an untapped workforce of domain experts.WorkAround's platform enables simple, quick annotation of data. Anything from classifying expenses into tax codes, annotating breast tissue to identify regions of interest, to identifying drug combinations fromclinical trial reports. We have the domain experts and a platform to facilitate a simple, secure processing of customer data and annotations.Companies that using WorkAround services not only save time and get quality service, but are also contributing to a more socially just and productive world where talent knows no boundaries, opportunity doesn’t ask for status, and work is rewarded with fair pay.
Show all investments...

Jessica Livingston
Angel · Palo Alto, California, United States · 1 investments in Mexico Biotech startups

Jessica Livingston is a Co-founding partner. She is also the organizer of Startup School, the big annual startup conference, and the author of Founders at Work, a collection of interviews with successful startup founders.

Show more...

Investment focus

  • Industry: Medical Device, Education, Health Care
  • Stage:Seed, Angel
  • Geography: United States, Mexico

Investor stats

  • Total investments: 13
  • Lead/follow: no public data

Portfolio highlights

  • Balto — Balto, the sports gaming platform made for the casual, everyday fan. We’re thrilled to have you. As a quick intro, we’re Nick Montana, Spencer Cassidy and Joel Karacozoff, three individuals with a passion for gaming and an affinity for bringing people together. As driven co-founders to deliver the best experience, They have set out to create asimple, social and fun gaming interface for all.
  • Elpha — Elpha is where women succeed at work together. Become a member to access daily conversations with experts, insider job opportunities, and a lot of women talking candidly about work and life. Plus membership is free!
  • Hype and Vice — Hype and Vice combines on-trend fashion with University brands to create officially licensed college apparel women! Cool college apparel to wear for tailgates and gamedays or to lounge around your dorm.
Show all investments...

Bob Goodman
Angel · New York, New York, United States · 1 investments in Mexico Biotech startups

Robert Goodman is a general partner at Goodman served as a director at he joined Bessemer Venture Partners. He has also worked at Goodman holds a bachelor’s degree in arts from

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Series B, Series C, Series A
  • Geography: United States, Mexico, Germany

Investor stats

  • Total investments: 31
  • Lead/follow: no public data

Portfolio highlights

  • Formally — Formally is a platform for legal collaboration. We leverage intelligent technology with behavioral science to create a whole new category of legal tech. And it all starts with immigration.
  • Tackle — Tackle helps you identify the right buyers, co-sell with your Cloud Partners, and transact through the Marketplaces with a platform built for Cloud GTM success.
  • Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Ashton Kutcher
Angel · Los Angeles, California, United States · 1 investments in Mexico Biotech startups

Ashton Kutcher is an actor, investor, entrepreneur, producer and philanthropist.Kutcher has been named one of TIME magazine’s “100 Most Influential People in the World,” as well as being honored by Vanity Fair ‘s “New Establishment List,” which identifies the top 50 of an innovative new breed of buccaneering visionaries, engineering prodigiesand entrepreneurs. Twice, Kutcher was named one of Forbes magazine’s “World’s Most Powerful Celebrities,” as well as one of Fast Company magazine’s “Most Creative People.”Kutcher has been investing in technology for over a decade, both as an angel investor and a founding partner of A-Grade Investments and Sound Ventures. His fund portfolio includes Airbnb, Uber, Flexport, Brex, Robinhood, Bird, Airtable and Affirm among others.Kutcher is also the co-founder of Thorn: Digital Defenders of Children (www.thorn.org). Thorn drives technology innovation to fight the sexual exploitation of children.Kutcher currently stars in the Netflix original series, The Ranch. He also serves as Executive Producer. Until 2015, Kutcher starred in the CBS comedy series Two and a Half Men. The show ranked as the second most-watched comedy on all of network television. Kutcher first gained recognition as Michael Kelso on the Fox series That 70’s Show, and went on to star in a variety of box office hits on the big screen – including What Happens In Vegas with Cameron Diaz, The Guardian with Kevin Costner, No Strings Attached with Natalie Portman and the cult hit Dude, Where’s My Car.Kutcher served as co-creator and producer of MTV's hit series, “Punk'd,” and The CW's reality series “Beauty and the Geek” and “True Beauty.” He has also produced films such as No Strings Attached, Killers and The Butterfly Effect. Additionally, Kutcher co-founded APlus, a digital media company devoted to spreading the message of positive journalism, a kind of storytelling that focuses on our shared humanity. In 2016, APlus was purchased by Chicken Soup for the Soul.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Apps
  • Stage:Seed, Series A, Series B
  • Geography: United States, Germany, Canada

Investor stats

  • Total investments: 111
  • Lead/follow: no public data

Portfolio highlights

  • QD-SOL — QD-SOL uses nanoparticles to produce green hydrogen in half the time.
  • Spicewell — Spicewell develops and creates food seasoning products that includes various kinds of micronutrients. It uses modern science to infuse healthy and organic additions to food meals. Spicewell is based in California, USA.
  • HempNFibers — Growing hemp. Making a bio fuel to start. Than also an insulation out of it as well. Will look at doing more as company grows. I also know a way to power a whole warehouse by just the plants it’s self but I need funding to get this started. I’m building the transportation side just so I can gain an income to try and get this started.
Show all investments...

Eric Urhane
Angel · 1 investments in Mexico Biotech startups

Eric Urhane

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Angel
  • Geography: United States, Mexico, Singapore

Investor stats

  • Total investments: 5
  • Round size: Seed $1.1M–$1.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • X-ZELL — Early, pain-free cancer cell detection
  • Chirply — Chirply is a platform for crowd-sourcing & crowd-curating design. Chirply's mission is to build engagement, stickiness, and virality through crowd-sourcing design. Initially the company focused on the launch of a marketplace for crowd-sourced design for paper goods - an industry that hasn't been disrupted since the advent of theprinting press. Chirply then launched a B2B platform for crowd-sourced design for brands to help engage users and use design to make daily products inspiring.
Show all investments...

Elizabeth Iorns
Angel · Palo Alto, California, United States · 1 investments in Mexico Biotech startups

Elizabeth Iorns is the Co-Founder, President, and CEO of Science Exchange. She previously worked at Y Combinator as a Part-time partner. Elizabeth Iorns attended the University of Auckland.

Show more...

Investment focus

  • Industry: Software, SaaS, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 6
  • Round size: Seed $1.9M–$3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Torch — Transform your organization with Torch's leadership development solutions and drive lasting sustainable change.
  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • Enzyme — Enzyme QMS software includes modules for all stages of the product development life cycle from Design Control to CAPA. Our in-house experts are here to back you up! We can guide you through the quality challenges and regulatory submission process. Sign up for a Demo today.
Show all investments...

Dan Knox
Angel · San Francisco, California, United States · 1 investments in Mexico Biotech startups

Dan Knox is one of the founders of Science Exchange, an online marketplace for science experiments. Prior to founding Science Exchange, Dan was Head of Operations at DailyMe, a pioneer in the field of dynamic personalization and predictive content and commerce presentation. Before joining DailyMe, Dan was Head of Economic Analysis within in theStrategy team at a leading commercial television network in the U.K., and a Senior Economist in the Media & Communications group of a global expert services consulting firm.Dan was part of the inaugural Executive MBA class at MIT Sloan School of Management. He also has a Master's degree and a Bachelor's degree in Economics, a Law degree and the Chartered Financial Analyst (CFA) qualification.

Show more...

Investment focus

  • Industry: Finance, Health Care, Crowdfunding
  • Stage:Seed
  • Geography: Mexico, United States

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • Experiment — Experiment is an online community and a crowdfunding platform for scientific research. It provides crowdfunding services for scientific research related to categories such as biology, chemistry, computer science, medicine, anthropology, psychology, engineering, and more.The platform provides its services for researchers from over 150institutions and universities around the world. It is in strategic partnerships with Experiment was founded by
Show all investments...

Jeff Horing
Angel · New York, New York, United States · 1 investments in Mexico Biotech startups, 10 in the past 12 months

Jeff Horing is based out of New York, New York and is the Managing Director of Insight Partners. Jeff previously worked at E.M. Warburg, Pincus & Co as a Team Member. Jeff Horing attended the University of Pennsylvania.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Series B, Series A, Series C
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 91
  • Round size: Series A $8.7M–$125M; Series B $24M–$115M; Series C $42M–$210M
  • Lead/follow: 78% lead, 22% follow

Portfolio highlights

  • FloVision Solutions — Food Analytics to maximize profits and minimize waste. FloWaste allows food service providers to optimize meal preparation, ingredient combinations, and portion sizing
  • Atarraya Inc — Explore Atarraya Farms commitment to sustainability and ethical seafood production. We create the most sustainable protein in the world through innovative aquaculture practices. Join us in revolutionizing the future of seafood
  • Airis Labs — Airis Labs provides a platform that turns user-generated content into field intelligence. The system extracts information from videos, images, audio, and text to help identify threats. It processes large amounts of unstructured data to support investigations and monitoring. The platform reduces time spent reviewing footage by automating theanalysis process. It offers high accuracy in locating urban areas from visual data. Airis combines multiple tools into one system for intelligence gathering and threat mapping. The platform can be deployed on private servers or through cloud networks.
Show all investments...

Biotech Angel investor funding in Mexico at a glance

Stats across 3 deals from 15 investors.

15
investors
in Mexico Biotech startups
3
deals
in Mexico Biotech startups
$3.9M
median round
in Mexico Biotech startups
7%
lead investors
lead at least one round
33%
Series A
most common funding stage

Access all 15 angel investors in Mexico Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Angel Investors in Mexico investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 15 angel investors investing in Mexico Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists